Restoration of cefixime-induced gut microbiota changes by Lactobacillus cocktails and fructooligosaccharides in a mouse model

Microbiological Research

Volumn 200, Issue , 2017, Pages 14-24

  Shi, Ying ^a   Zhai, Qixiao ^a   Li, Dongyao ^a   Mao, Bingyong ^a   Liu, Xiaoming ^a   Zhao, Jianxin ^a   Zhang, Hao ^a   Chen, Wei ^a,b  

^a JIANGNAN UNIVERSITY   (China)

^b BEIJING TECHNOLOGY AND BUSINESS UNIVERSITY   (China)

Author keywords

Alteration; Antibiotic; Gut microbiota; Lactobacillus; Short chain fatty acids

Indexed keywords

ANTIBIOTICS; CELL ADHESION; CHAINS; FOOD ADDITIVES; MAMMALS; RESTORATION;

ALTERATION; FRUCTOOLIGOSACCHARIDES; GASTROINTESTINAL TRACT; GUT MICROBIOTA; INTESTINAL INFLAMMATION; LACTOBACILLUS; MICROBIAL COMMUNITIES; SHORT-CHAIN FATTY ACIDS;

FATTY ACIDS;

ANTIBIOTICS; BACTERIUM; COMMUNITY DYNAMICS; DIGESTIVE SYSTEM; FATTY ACID; INDUCED RESPONSE; MICROBIAL COMMUNITY; PROBIOTICS; RODENT; SPECIES DIVERSITY; SUGAR;

AKKERMANSIA; FIRMICUTES; LACTOBACILLUS; MUS;

BACTERIAL DNA; CEFIXIME; FRUCTOSE OLIGOSACCHARIDE; OLIGOSACCHARIDE; PROBIOTIC AGENT; RNA 16S; VOLATILE FATTY ACID;

ANIMAL; BLOOD ANALYSIS; C57BL MOUSE; CECUM; CELL ADHESION; CHEMISTRY; CLASSIFICATION; COLON; DISEASE MODEL; DRUG EFFECTS; FECES; GASTROINTESTINAL TRACT; GENETICS; HT-29 CELL LINE; HUMAN; ILEUM; INTESTINE; INTESTINE FLORA; ISOLATION AND PURIFICATION; LACTOBACILLUS; MALE; METABOLISM; METAGENOMICS; MICROBIAL CONSORTIUM; MICROBIOLOGY; MOUSE; PATHOLOGY; PHYSIOLOGY;

ANIMALS; BLOOD CHEMICAL ANALYSIS; CECUM; CEFIXIME; CELL ADHESION; COLON; DISEASE MODELS, ANIMAL; DNA, BACTERIAL; FATTY ACIDS, VOLATILE; FECES; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HT29 CELLS; HUMANS; ILEUM; INTESTINES; LACTOBACILLUS; MALE; METAGENOMICS; MICE; MICE, INBRED C57BL; MICROBIAL CONSORTIA; OLIGOSACCHARIDES; PROBIOTICS; RNA, RIBOSOMAL, 16S;

EID: 85017211170     PISSN: 09445013     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micres.2017.04.001     Document Type: Article

References (62)

1. Akrami, R., Iri, Y., Khoshbavar Rostami, H., Razeghi Mansour, M., Effect of dietary supplementation of fructooligosaccharide (FOS) on growth performance, survival, lactobacillus bacterial population and hemato-immunological parameters of stellate sturgeon (Acipenser stellatus) juvenile. Fish Shellfish Immunol. 35:4 (2013), 1235–1239.
2. Arthur, J.C., Perez Chanona, E., Mühlbauer, M., Tomkovich, S., Uronis, J.M., Fan, T.J., Campbell, B.J., Abujamel, T., Dogan, B., Rogers, A.B., Rhodes, J.M., Stintzi, A., Simpson, K.W., Hansen, J.J., Keku, T.O., Fodor, A.A., Jobin, C., Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 338:6103 (2012), 120–123.
3. Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D.R., Fernandes, G.R., Tap, J., Bruls, T., Batto, J.M., Bertalan, M., Borruel, N., Casellas, F., Fernandez, L., Gautier, L., Hansen, T., Hattori, M., Hayashi, T., Kleerebezem, M., Kurokawa, K., Leclerc, M., Levenez, F., Manichanh, C., Nielsen, H.B., Nielsen, T., Pons, N., Poulain, J., Qin, J., Sicheritz Ponten, T., Tims, S., Torrents, D., Ugarte, E., Zoetendal, E.G., Wang, J., Guarner, F., Pedersen, O., de Vos, W.M., Brunak, S., Dore, J., Meta, H.I.T.C., Antolin, M., Artiguenave, F., Blottiere, H.M., Almeida, M., Brechot, C., Cara, C., Chervaux, C., Cultrone, A., Delorme, C., Denariaz, G., Dervyn, R., Foerstner, K.U., Friss, C., van de Guchte, M., Guedon, E., Haimet, F., Huber, W., van Hylckama Vlieg, J., Jamet, A., Juste, C., Kaci, G., Knol, J., Lakhdari, O., Layec, S., Le Roux, K., Maguin, E., Merieux, A., Melo Minardi, R., M'Rini, C., Muller, J., Oozeer, R., Parkhill, J., Renault, P., Rescigno, M., Sanchez, N., Sunagawa, S., Torrejon, A., Turner, K., Vandemeulebrouck, G., Varela, E., Winogradsky, Y., Zeller, G., Weissenbach, J., Ehrlich, S.D., Bork, P., Enterotypes of the human gut microbiome. Nature 473:7346 (2011), 174–180.
4. Bron, P.A., van Baarlen, P., Kleerebezem, M., Emerging molecular insights into the interaction between probiotics and the host intestinal mucosa. Nat. Rev. Microbiol. 10:1 (2012), 66–78.
5. Canfora, E.E., Jocken, J.W., Blaak, E.E., Short-chain fatty acids in control of body weight and insulin sensitivity. Nat. Rev. Endocrinol. 11:10 (2015), 577–591.
6. Caporaso, J.G., Bittinger, K., Bushman, F.D., DeSantis, T.Z., Andersen, G.L., Knight, R., PyNAST: a flexible tool for aligning sequences to a template alignment. Bioinformatics 26:2 (2010), 266–267.
7. Caporaso, J.G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F.D., Costello, E.K., Fierer, N., Pena, A.G., Goodrich, J.K., Gordon, J.I., Huttley, G.A., Kelley, S.T., Knights, D., Koenig, J.E., Ley, R.E., Lozupone, C.A., McDonald, D., Muegge, B.D., Pirrung, M., Reeder, J., Sevinsky, J.R., Tumbaugh, P.J., Walters, W.A., Widmann, J., Yatsunenko, T., Zaneveld, J., Knight, R., QIIME allows analysis of high-throughput community sequencing data. Nat. Mthods 7:5 (2010), 335–336.
8. Casarotti, S.N., Todorov, S.D., Penna, A.L.B., Effect of different matrices on probiotic resistance to in vitro simulated gastrointestinal conditions. Int. J. Dairy Technol. 68:4 (2015), 595–601.
9. Clavel, T., Charrier, C., Braune, A., Wenning, M., Blaut, M., Haller, D., Isolation of bacteria from the ileal mucosa of TNFdeltaARE mice and description of Enterorhabdus mucosicola gen. nov., sp. nov. Int. J. Syst. Evol. Microbiol. 59:7 (2009), 1805–1812.
10. Clavel, T., Duck, W., Charrier, C., Wenning, M., Elson, C., Haller, D., Enterorhabdus caecimuris sp. nov, a member of the family Coriobacteriaceae isolated from a mouse model of spontaneous colitis, and emended description of the genus Enterorhabdus. Int. J. Syst. Evol. Microbiol. 60:7 (2010), 1527–1531.
11. Coburn, B., Li, Y., Owen, D., Vallance, B.A., Finlay, B.B., Salmonella enterica serovar Typhimurium pathogenicity island 2 is necessary for complete virulence in a mouse model of infectious enterocolitis. Infect. Immun. 73:6 (2005), 3219–3227.
12. Collado, M.C., Derrien, M., Isolauri, E., de Vos, W.M., Salminen, S., Intestinal integrity and Akkermansia muciniphila, a mucin-degrading member of the intestinal microbiota present in infants, adults, and the elderly. Appl. Environ. Microbiol. 73:23 (2007), 7767–7770.
13. Dao, M.C., Everard, A., Aron-Wisnewsky, J., Sokolovska, N., Prifti, E., Verger, E.O., Kayser, B.D., Levenez, F., Chilloux, J., Hoyles, L., Consortium, M.I.-O., Dumas, M.E., Rizkalla, S.W., Dore, J., Cani, P.D., Clement, K., Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut 65:3 (2016), 426–436.
14. Derrien, M., Collado, M.C., Ben Amor, K., Salminen, S., de Vos, W.M., The mucin degrader Akkermansia muciniphila is an abundant resident of the human intestinal tract. Appl. Environ. Microbiol. 74:5 (2008), 1646–1648.
15. Dylewski, J., Psaradellis, E., Sampalis, J., Efficacy of BIO K + CL1285 (R) in the reduction of antibiotic-associated diarrhea a placebo controlled double-blind randomized, multi-center study. Arch. Med. Sci. 6:1 (2010), 56–64.
16. Eeckhaut, V., Machiels, K., Perrier, C., Romero, C., Maes, S., Flahou, B., Steppe, M., Haesebrouck, F., Sas, B., Ducatelle, R., Vermeire, S., Van Immerseel, F., Butyricicoccus pullicaecorum in inflammatory bowel disease. Gut 62:12 (2013), 1745–1752.
17. Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J.P., Druart, C., Bindels, L.B., Guiot, Y., Derrien, M., Muccioli, G.G., Delzenne, N.M., de Vos, W.M., Cani, P.D., Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. PNAS 110:22 (2013), 9066–9071.
18. Femia, A.P., Luceri, C., Dolara, P., Giannini, A., Biggeri, A., Salvadori, M., Clune, Y., Collins, K.J., Paglierani, M., Caderni, G., Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats. Carcinogenesis 23:11 (2002), 1953–1960.
19. Fernández, M.F., Boris, S., Barbés, C., Probiotic properties of human lactobacilli strains to be used in the gastrointestinal tract. J. Appl. Microbiol. 94:3 (2003), 449–455.
20. Gao, X.W., Mubasher, M., Fang, C.Y., Reifer, C., Miller, L.E., Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patients. Am. J. Gastroenterol. 105:7 (2010), 1636–1641.
21. Geirnaert, A., Steyaert, A., Eeckhaut, V., Debruyne, B., Arends, J.B.A., Van Immerseel, F., Boon, N., Van de Wiele, T., Butyricicoccus pullicaecorum, a butyrate producer with probiotic potential, is intrinsically tolerant to stomach and small intestine conditions. Anaerobe 30 (2014), 70–74.
22. Gonzales, R., Malone, D.C., Maselli, J.H., Sande, M.A., Excessive antibiotic use for acute respiratory infections in the United States. Clin. Infect. Dis. 33:6 (2001), 757–762.
23. Goulet, O., Potential role of the intestinal microbiota in programming health and disease. Nutr. Rev. 73:1 (2015), 32–40.
24. Guarner, F., Malagelada, J.R., Gut flora in health and disease. Lancet 361:9356 (2003), 512–519.
25. Hammer, H.F., Gut microbiota and inflammatory bowel disease. Dig. Dis. 29:6 (2011), 550–553.
26. Hickson, M.D., Souza, A.L., Muthu, N., Rogers, T.R., Want, S., Rajkumar, C., Bulpitt, C.J., Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics randomised double blind placebo controlled trial. BMJ 335:7610 (2007), 80–83.
27. Hill, D.A., Hoffmann, C., Abt, M.C., Du, Y., Kobuley, D., Kirn, T.J., Bushman, F.D., Artis, D., Metagenomic analyses reveal antibiotic-induced temporal and spatial changes in intestinal microbiota with associated alterations in immune cell homeostasis. Mucosal Immunol. 3:2 (2009), 148–158.
28. Hungin, A.P.S., Mulligan, C., Pot, B., Whorwell, P., Agreus, L., Fracasso, P., Lionis, C., Mendive, J., de Foy, J.M.P., Rubin, G., Winchester, C., de Wit, N., European Soc Primary, C., Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice-an evidence-based international guide. Aliment. Pharmacol. Ther. 38:8 (2013), 864–886.
29. Kato, T., Fukuda, S., Fujiwara, A., Suda, W., Hattori, M., Kikuchi, J., Ohno, H., Multiple omics uncovers host-gut microbial mutualism during prebiotic fructooligosaccharide supplementation. DNA Res. 21:5 (2014), 469–480.
30. Kronman, M.P., Zhou, C., Mangione-Smith, R., Bacterial prevalence and antimicrobial prescribing trends for acute respiratory tract infections. Pediatrics 134:4 (2014), 956–965.
31. Ladirat, S.E., Schols, H.A., Nauta, A., Schoterman, M.H.C., Keijser, B.J.F., Montijn, R.C., Gruppen, H., Schuren, F.H.J., High-throughput analysis of the impact of antibiotics on the human intestinal microbiota composition. J. Microbiol. Methods 92:3 (2013), 387–397.
32. Ladirat, S.E., Schoterman, M.H.C., Rahaoui, H., Mars, M., Schuren, F.H.J., Gruppen, H., Nauta, A., Schols, H.A., Exploring the effects of galacto-oligosaccharides on the gut microbiota of healthy adults receiving amoxicillin treatment. Br. J. Nutr. 112:4 (2014), 536–546.
33. Lozupone, C., Knight, R., UniFrac: a new phylogenetic method for comparing microbial communities. Appl. Environ. Microbiol. 71:12 (2005), 8228–8235.
34. Mao, B.Y., Li, D.Y., Zhao, J.X., Liu, X.M., Gu, Z.N., Chen, Y.Q., Zhang, H., Chen, W., Metagenomic insights into the effects of fructo-oligosaccharides (FOS) on the composition of fecal microbiota in mice. J. Agric. Food Chem. 63:3 (2015), 856–863.
35. McCaig, L.F., Besser, R.E., Hughes, J.M., Antimicrobial drug prescription in ambulatory care settings, United States, 1992–2000. Emerg. Infect. Dis. 9:4 (2003), 432–437.
36. Millette, M., Nguyen, A., Amine, K.M., Lacroix, M., Gastrointestianl survival of bacteria in commercial probiotic products. Int. J. Probiot. Prebiot. 8:4 (2013), 149–156.
37. Murphy, E.F., Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models. Gut 59:12 (2010), 1635–1642.
38. Nechvatal, J.M., Ram, J.L., Basson, M.D., Namprachan, P., Niec, S.R., Badsha, K.Z., Matherly, L.H., Majumdar, A.P., Kato, I., Fecal collection, ambient preservation, and DNA extraction for PCR amplification of bacterial and human markers from human feces. J. Microbiol. Methods 72:2 (2008), 124–132.
39. Ng, K.M., Ferreyra, J.A., Higginbottom, S.K., Lynch, J.B., Kashyap, P.C., Gopinath, S., Naidu, N., Choudhury, B., Weimer, B.C., Monack, D.M., Sonnenburg, J.L., Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens. Nature 502:7469 (2013), 96–99.
40. Paturi, G., Butts, C.A., Bentley-Hewitt, K.L., Hedderley, D., Stoklosinski, H., Ansell, J., Differential effects of probiotics, prebiotics, and synbiotics on gut microbiota and gene expression in rats. J. Funct. Foods 13 (2015), 204–213.
41. Pennacchia, C., Vaughan, E.E., Villani, F., Potential probiotic Lactobacillus strains from fermented sausages: further investigations on their probiotic properties. Meat Sci. 73:1 (2006), 90–101.
42. Peran, L., Camuesco, D., Comalada, M., Nieto, A., Concha, A., Adrio, J.L., Olivares, M., Xaus, J., Zarzuelo, A., Galvez, J., Lactobacillus fermentum, a probiotic capable to release glutathione, prevents colonic inflammation in the TNBS model of rat colitis. Int. J. Colorectal Dis. 21:8 (2006), 737–746.
43. Pisano, M.B., Viale, S., Conti, S., Fadda, M.E., Deplano, M., Melis, M.P., Deiana, M., Cosentino, S., Preliminary evaluation of probiotic properties of Lactobacillus strains isolated from Sardinian dairy products. Biomed. Res. Int. 286390 (2014), 1–9, 10.1155/2014/286390.
44. Plummer, S., Weaver, M.A., Harris, J.C., Dee, P., Hunter, J., Clostridium difficile pilot study: effects of probiotic supplementation on the incidence of C. difficile diarrhoea. Int. Microbiol. 7:1 (2004), 59–62.
45. Price, M.N., Dehal, P.S., Arkin, A.P., FastTree: computing large minimum evolution trees with profiles instead of a distance matrix. Mol. Biol. Evol. 26:7 (2009), 1641–1650.
46. Sánchez, E., De Palma, G., Capilla, A., Nova, E., Pozo, T., Castillejo, G., Varea, V., Marcos, A., Garrote, J.A., Polanco, I., López, A., Ribes Koninckx, C., García Novo, M.D., Calvo, C., Ortigosa, L., Palau, F., Sanz, Y., Influence of environmental and genetic factors linked to celiac disease risk on infant gut colonization by Bacteroides species. Appl. Environ. Microbiol. 77:15 (2011), 5316–5323.
47. Scanlan, P.D., Shanahan, F., Clune, Y., Collins, J.K., O'Sullivan, G.C., O'Riordan, M., Holmes, E., Wang, Y., Marchesi, J.R., Culture-independent analysis of the gut microbiota in colorectal cancer and polyposis. Environ. Microbiol. 10:3 (2008), 789–798.
48. Shin, N.R., Lee, J.C., Lee, H.Y., Kim, M.S., Whon, T.W., Lee, M.S., Bae, J.W., An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut 63:5 (2014), 727–735.
49. Smith, C.L., Geier, M.S., Yazbeck, R., Torres, D.M., Butler, R.N., Howarth, G.S., Lactobacillus fermentum BR11 and fructo-oligosaccharide partially reduce jejunal inflammation in a model of intestinal mucositis in rats. Nutr. Cancer 60:6 (2008), 757–767.
50. Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Humaràn, Bermüdez, Gratadoux, L.G., Blugeon, J.J., Bridonneau, S., Furet, C., Corthier, J.P., Grangette, G., Vasquez, C., Pochart, N., Trugnan, P., Thomas, G., Blottiére, G., Doré, H.M., Marteau, J., Seksikt, P., Langella, P., Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. PNAS 105:43 (2008), 16731–16736.
51. Song, H.J., Kim, J.Y., Jung, S.A., Kim, S.E., Park, H.S., Jeong, Y., Hong, S.P., Cheon, J.H., Kim, W.H., Kim, H.J., Ye, B.D., Yang, S.K., Kim, S.W., Shin, S.J., Kim, H.S., Sung, J.K., Kim, E.Y., Effect of probiotic Lactobacillus (Lacidofil(R) cap) for the prevention of antibiotic-associated diarrhea: a prospective, randomized, double-blind, multicenter study. J. Korean Med. Sci. 25:12 (2010), 1784–1791.
52. Theriot, C.M., Koenigsknecht, M.J., Carlson, P.E. Jr., Hatton, G.E., Nelson, A.M., Li, B., Huffnagle, G.B., Li, J.Z., Young, V.B., Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection. Nat. Commun., 5, 2014, 3114, 10.1038/ncomms4114.
53. Velicer, C.M.H.S., Lampe, J.W., Potter, J.D., Robertson, C.A., Taplin, S.H., Antibiotic use in relation to the risk of breast cancer. Jama 291:7 (2004), 827–835.
54. Vizoso Pinto, M.G., Franz, C.M.A.P., Schillinger, U., Holzapfel, W.H., Lactobacillus spp. with in vitro probiotic properties from human faeces and traditional fermented products. Int. J. Food Microbiol. 109:3 (2006), 205–214.
55. Wang, Q., Garrity, G.M., Tiedje, J.M., Cole, J.R., Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl. Environ. Microbiol. 73:16 (2007), 5261–5267.
56. Wang, T., Cai, G., Qiu, Y., Fei, N., Zhang, M., Pang, X., Jia, W., Cai, S., Zhao, L., Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J. 6:2 (2012), 320–329.
57. Wen, L., Ley, R.E., Volchkov, P.Y., Stranges, P.B., Avanesyan, L., Stonebraker, A.C., Hu, C., Wong, F.S., Szot, G.L., Bluestone, J.A., Gordon, J.I., Chervonsky, A.V., Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 455:7216 (2008), 1109–1113.
58. Zhao, G.H., Nyman, M., Jonsson, J.A., Rapid determination of short-chain fatty acids in colonic contents and faeces of humans and rats by acidified water-extraction and direct-injection gas chromatography. Biomed. Chromatogr. 20:8 (2006), 674–682.
59. Zhao, L.L., Wang, G., Siegel, P., He, C., Wang, H.Z., Zhao, W.J., Zhai, Z.X., Tian, F.W., Zhao, J.X., Zhang, H., Sun, Z.K., Chen, W., Zhang, Y., Meng, H., Quantitative genetic background of the host influences gut microbiomes in chickens. Sci. Rep., 3, 2013, 1163, 10.1038/Srep01163.
60. Zhao, Y., Wu, J., Li, J.V., Zhou, N.Y., Tang, H., Wang, Y., Gut microbiota composition modifies fecal metabolic profiles in mice. J. Proteome Res. 12:6 (2013), 2987–2999.
61. de Theije, C.G., Wopereis, H., Ramadan, M., van Eijndthoven, T., Lambert, J., Knol, J., Garssen, J., Kraneveld, A.D., Oozeer, R., Altered gut microbiota and activity in a murine model of autism spectrum disorders. Brain Behav. Immun. 37 (2014), 197–206.
62. de Vrese, M., Kristen, H., Rautenberg, P., Laue, C., Schrezenmeir, J., Probiotic lactobacilli and bifidobacteria in a fermented milk product with added fruit preparation reduce antibiotic associated diarrhea and Helicobacter pylori activity. J. Dairy Res. 78:4 (2011), 396–403.